Dec 14 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT REGARDING COMPANY'S PHASE 2B PLACEBO CONTROLLED OA/BMEL CLINICAL TRIAL RESULTS
Dec 14 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT REGARDING COMPANY'S PHASE 2B PLACEBO CONTROLLED OA/BMEL CLINICAL TRIAL RESULTS